# Preoperative Bexarotene Treatment for Cushing's Disease

> **NCT00845351** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 6 (estimated)

## Conditions studied

- Cushing's Disease

## Interventions

- **DRUG:** Bexarotene

## Key facts

- **NCT ID:** NCT00845351
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2011-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845351, "Preoperative Bexarotene Treatment for Cushing's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00845351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*